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Objectives: To document the prevalence of cardiac abnormalities in dogs with steroid-responsive menin-
gitis arteritis and to assess resolution of these abnormalities following corticosteroid therapy.
Materials and MethOds: Steroid-responsive meningitis arteritis was diagnosed based on signalment, 
physical examination findings, complete blood count, biochemistry and CSF analysis. Echocardiography, 
C-reactive protein and cardiac troponin I were measured in all cases before and 10 to 14 days after 
commencing corticosteroid therapy. Fibrinogen was also measured in a proportion of dogs.
results: Fourteen dogs were prospectively enrolled. Increased cardiac troponin I was identified in five 
of 14 dogs and echocardiographic abnormalities were detected in 12 of 14 dogs, including spontane-
ous echo contrast (12 of 14), mild pericardial effusion (five of 14) and mildly decreased fractional 
shortening (five of 14). All dogs had increased C-reactive protein and fibrinogen was increased in 11 of 
12. Corticosteroid treatment was associated with clinical improvement and normalisation of 
C-reactive protein in all dogs. The cardiac troponin I levels normalised in four of five and fibrinogen had 
normalised in all five dogs which were retested. Spontaneous echo contrast improved or completely 
resolved in 12 of 12 and pericardial effusion resolved in five of five dogs. Fractional shortening normal-
ised in two of five dogs.
clinical significance: Cardiac changes are common in dogs with steroid-responsive meningitis arteritis 
and most resolve with therapy. Further investigation into the cause and significance of these changes 
is necessary in determining whether antithrombotic therapy or positive inotropic therapy is indicated.
INTRODUCTION
Steroid-responsive meningitis arteritis (SRMA) is an inflamma-
tory disease of the central nervous system (CNS) that typically 
affects young dogs (Cizinauskas et al. 2000). An immune-
mediated aetiology is strongly suspected based on the high 
titres of IgA documented in both the serum and cerebrospinal 
fluid (CSF) of affected dogs, the rapid clinical improvement 
commonly seen following corticosteroid administration and 
the lack of identification of infectious disease (Maiolini et al. 
2012). Breed predilection is recognised in numerous breeds, 
including beagles, boxers and Weimaraners (Harcourt 1978, 
Poncelet & Balligand 1993, Lowrie et al. 2009b). Response 
to treatment in dogs with SRMA can be monitored by various 
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methods including repeat CSF analysis or serial measurement 
of the acute phase protein C-reactive protein (CRP), which is 
a non-invasive and sensitive marker of clinical remission and 
a predictive marker of disease relapse (Bathen-Noethen et al. 
2008, Lowrie et al. 2009a).
The co-occurrence of cardiac disease and inflammatory 
CNS disease in people is recognised. Myocarditis and arrhyth-
mias can occur and are thought to be due to myocyte dam-
age from circulating inflammatory mediators and stimulation 
of the sympathetic nervous system, respectively (Linde et al. 
2006). In humans with bacterial meningitis, concurrent myo-
carditis and purulent pericardial effusion have been reported 
(Stange et al. 2001) along with a reactive pericardial effusion 
that responded to corticosteroid administration (Berti et al. 
2013). Pericarditis with a mild effusion is also the most com-
mon cardiac manifestation of systemic lupus erythematosus 
in humans and this resolves with immunosuppressive therapy 
(Rosenbaum et al. 2009). An immune-mediated aetiology has 
not been proven in dogs with pericardial effusion (Day & 
Martin 2002).
Cardiac troponin I (cTnI) is extensively used as a marker 
of cardiac myocyte damage in dogs but has been shown to be 
non-specific, increasing in various cardiac and non-cardiac con-
ditions (Langhorn & Willesen 2016). Left ventricular systolic 
dysfunction, pericardial effusion and increased cTnI have been 
reported in five dogs with SRMA (Covey & Connolly 2018). 
These patients did not show clinical signs of cardiac disease and 
their pericardial effusion resolved without therapeutic pericar-
diocentesis. Epicarditis and myocarditis have also been reported 
in histopathological examinations of beagles with SRMA as part 
of a polyarteritis syndrome (Snyder et al. 1995). In addition, 
two separate case reports have documented myocarditis associ-
ated with SRMA: based on ECG abnormalities and increased 
cTnI in one case (Snyder et al. 2010), and a pericardial effu-
sion, increased cTnI and spontaneous echocontrast that resolved 
following treatment of SRMA in another (Navarro-Cubas et al. 
2011). Neither of these patients presented with clinical signs of 
cardiac disease.
SRMA can be associated with multi-systemic inflammation 
and has also been shown to occur concurrently with non-cardio-
genic pathological processes including immune-mediated polyar-
thritis (Webb et al. 2002). Panarteritis was reported in laboratory 
beagles with SRMA (Scott-Moncrieff et al. 1992) that underwent 
post mortem examination, revealing necrotising arteritis most 
commonly involving the small- to medium-sized vessels of the 
cervical spinal cord, mediastinum and heart.
The primary aim of this study was to document the occur-
rence of echocardiographic abnormalities and myocardial 
injury (as documented by increased cTnI) in dogs diagnosed 
with SRMA. We specifically wanted to assess dogs for sponta-
neous echocontrast and idiopathic pericardial effusion, while 
determining whether these dogs had evidence of systemic 
inflammation by measuring CRP and fibrinogen. The sec-
ondary aim was to determine whether any identified cardiac 
abnormalities resolved as the CRP normalised following corti-
costeroid therapy.
MATERIAL AND METHODS
The Ethics Committee at the University of Glasgow approved 
this prospective study. Dogs referred to the University of Glasgow 
Small Animal Hospital between April 2014 and April 2015 with 
clinical signs and signalment compatible with SRMA were eli-
gible for enrolment. Cases that received corticosteroids for the 
presenting complaint before referral were excluded, as well as 
patients with any pre-existing concurrent  disease diagnosed on 
history, physical examination or during investigations.
All patients had a detailed clinical history, full physical exami-
nation and routine haematology, serum biochemistry and CRP 
measured. Excess blood was analysed for cTnI and, in some cases, 
fibrinogen. CRP (Siemens Dimension Xpand Plus, Siemens 
Healthcare Ltd.) and cTnI (Siemens Immulite 2000, Siemens 
Healthcare Ltd.) were measured on serum samples and fibrino-
gen (KC4 Delta Amelung Semi-Automated Coagulation Ana-
lyzer, Trinity Biotech) on citrated whole blood at the hospital 
reference laboratory. Echocardiography was performed in all dogs 
before anaesthesia for CSF analysis and, or, cervical radiographs as 
deemed appropriate by the clinician (Lowrie et al. 2009b, Maiolini 
et al. 2012). There is no definitive ante mortem diagnostic test for 
SRMA so if these tests were supportive, a presumptive diagnosis 
of SRMA was made and dogs were treated with glucocorticoids.
The physical examination was performed by a board-certified 
neurologist and clinical signs suggestive of SRMA were consid-
ered to be spinal pain, lethargy and/or pyrexia. The CSF charac-
teristic suggestive of SRMA was sterile neutrophilic pleocytosis. 
Echocardiography was performed by a board-certified cardiolo-
gist or a cardiology resident under the supervision of a board-
certified cardiologist, using a GE Vivid 7 echocardiographic 
system with transducer selection (4, 5 or 10 MHz) depending 
on the size of the dog. Echocardiographic recordings were made 
with a simultaneous ECG and all data were stored for analysis. 
Standard imaging planes were used with the dog restrained in 
right or left lateral recumbency (Thomas et al. 1993). The echo-
cardiographic study was undertaken including 2D, M-mode, 
spectral and colour Doppler. No tissue Doppler imaging was 
undertaken. In all patients, echocardiographic measurements 
were made in two-dimensional mode for calculation of aorta 
and left atrial diameter and M-mode for left ventricular inter-
nal dimension at end-systole (LVIDs), left ventricular internal 
dimension at end diastole (LVIDd) and fractional shortening 
(FS). Left atrial diameter, left-ventricular-internal-dimension-
at-end-systole and left-ventricular-internal-dimension-at-end-
diastole measurements were normalised based on bodyweight 
as previously described (Cornell et al. 2004) before assessment. 
Pericardial effusion was noted when present and defined as mea-
suring less than 1 cm, with no cardiac tamponade. Spontaneous 
echo contrast was noted and graded as absent, mild or severe. A 
single-boarded cardiologist, blinded to cTnI results, reviewed all 
echocardiograms for the purpose of this study. If possible, echo-
cardiography was performed before administration of any drugs 
that could influence the results (anaesthetic, sedation or cortico-
steroids). Blood pressure was not measured in any patient.
S. Spence et al.
 
206 Journal of Small Animal Practice  •  Vol 60  •  April 2019  •  © 2019 The Authors. Journal of Small Animal Practice published by 
John Wiley & Sons Ltd on behalf of British Small Animal Veterinary Association.
Following diagnosis of SRMA, a corticosteroid treatment 
protocol was initiated as deemed appropriate by the clinician in 
charge, along with an individualised course of analgesia. Prednis-
olone therapy was adjusted as previously described (Lowrie et al. 
2009b). The patients were subsequently discharged once eating 
and when intravenous analgesia was no longer required.
Repeat evaluation was performed at 10 to 14 days and 
included neurological examination, echocardiography, CRP and 
cTnI measurement. In addition, fibrinogen was tested in a pro-
portion of patients.
RESULTS
Patients
Fourteen dogs diagnosed with SRMA were included in the 
study. Breeds represented included four boxers, two beagles, two 
whippets, three crossbreeds and three other breeds (one Afghan 
hound, one collie and one miniature poodle). Ten dogs were 
male (five neutered and five entire) and four were female (one 
neutered and three entire). The mean age was 12 months (range 
6 to 30 months).
Pre-treatment investigations
All dogs had neutrophilic pleocytosis in the CSF with an increase 
in nucleated cell count (population median 77 per mL, range 12 
to 1600; reference <5) without cytological evidence of bacteria. 
Increased protein was also found on CSF analysis in 11 of 14 
patients (population median 485 mg/L, 100 to 1868; reference 
<250). In addition, 11 of 11 dogs had normal cervical radio-
graphs. On haematology, 11 of 14 dogs showed neutrophilia 
(population median 14.92 × 109/L, range 7.12 to 31.25; reference 
3 to 11.8) and on biochemistry, six of 14 showed mild hypoalbu-
minaemia. All dogs had CRP measured before initiating therapy, 
and this was increased in all 14 patients (median 134 mg/L, range 
50 to 243; reference <10). Fibrinogen was measured in 12 of 14 
patients only, because of a lack of residual blood in the remaining 
two. It was increased in 11 of these patients (population median 
815 mg/dL, range 350 to 1112; reference <400). Pretreatment 
cardiac assessment involving cTnI measurement and echocar-
diography was performed in all dogs. The cTnI was increased in 
five of 14 dogs (population median 0.1 ng/L, range <0.1 to 14.5; 
reference <0.15).
One patient was incidentally diagnosed with mild subaortic 
stenosis with an aortic velocity of 2.46 m/s, reference <2.0 m/s 
(Boon 2011), without any structural changes noted on echo-
cardiography. Another was sedated with a low dose of 4 μg/kg 
medetomidine intravenously before referral. Mild left ventricular 
systolic dysfunction (defined by decreased FS) was noted in five 
of 14 dogs (population median 27%, range 20 to 36%; reference 
24 to 40%). Two dogs had increased normalised left ventricu-
lar internal dimension at end-systole (population median 1.11, 
range 0.79 to 1.35; reference 0.71 to 1.26), and one dog had 
increased normalised left-ventricular-internal-dimension-at-end-
diastole (population median 1.60, range 1.22 to 2.12; reference 
1.27 to 1.85). A mildly increased normalised left atrial diameter 
FIG 1. Right parasternal long-axis view of left atrium (LA) and ventricle 
(LV) showing (arrow) spontaneous echo contrast (SEC)
was noted in six of 14 dogs, although left atrial: aorta ratio was 
within normal range in all dogs (population median 1.28, range 
0.92 to 1.5).
Spontaneous echo contrast (Fig. 1) was found in the left ven-
tricle of 12 of 14 patients and mild pericardial effusion in five of 
14. All dogs with increased cTnI had spontaneous echo contrast 
identified on the echocardiogram. Also, all dogs with pericardial 
effusion had concurrent spontaneous echo contrast, but only 
two of five had an increase in cTnI. Two patients with increased 
fibrinogen had no evidence of spontaneous echo contrast and 
one patient with spontaneous echo contrast did not have an 
increase in fibrinogen. Five patients had pericardial effusion 
and five had decreased FS but only two patients had concurrent 
pericardial effusion and decreased FS. From descriptive analy-
sis of the results, there appeared to be no relationship between 
the CRP, cTnI, fibrinogen, FS or normalised left atrial diameter. 
Tables 1 and 2 summarise the clinicopathological and selected 
echocardiographic findings before and after treatment.
All dogs were started on therapy with prednisolone, with a 
total median daily dose of 2 mg/kg (range 0.9 to 2.1) for 2 weeks. 
In addition, 10 dogs were treated with concurrent omeprazole 
and two with famotidine. No dogs received cardiac medications 
or antithrombotic therapy. All dogs received injectable opioid 
analgesia during hospitalisation and in two dogs, oral tramadol 
was required for additional analgesia during this period.
After-treatment investigations
All patients showed significant clinical improvement on reevalu-
ation between 10 and 14 days after starting prednisolone, with 
complete resolution of signs in 11 of 14 patients and only mild 
neck pain on manipulation in the remaining three. The CRP was 
rechecked in all patients and found to be within reference range 
in 14 of 14. Fibrinogen was repeated in five of 12 cases and was 
within the normal range in all.
Repeat echocardiography was performed in all 14 patients. 
Of the five dogs with decreased FS, two normalised, three had 
Cardiac abnormalities in canine SRMA
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a further reduction in FS and two additional dogs developed 
reduction in FS (28 to 22% and 33 to 17%). Three dogs devel-
oped increased normalised left-ventricular-internal-dimension-
at-end-systole, one remained increased and one returned to 
normal. The spontaneous echo contrast had resolved in nine of 
12 patients and was subjectively improved in three of 12 patients. 
The mild pericardial effusion had completely resolved in five of 
five patients. Of the six of 12 patients with increased normalised 
left atrial diameter, four patients showed a mild (<5%) increase in 
diameter after treatment and two showed a mild (<5%) decrease, 
findings were considered to be within normal day-to-day vari-
ability (Cornell et al. 2004). Finally, the cTnI was rechecked 
in all patients and remained above the reference range in only 
one. In this individual, the level had increased from 0.59 ng/L 
before treatment to 2.47 ng/L. This patient was one of the three 
in which FS had been normal and was abnormal (<24%) on fol-
low-up. Fig. 2 summarises the changes of CRP, cTnI, fibrinogen, 
echocardiographic changes and clinical signs.
DISCUSSION
This study revealed that a high proportion of dogs with SRMA 
presented concurrent cardiac abnormalities (decreased FS, 
increased normalised left-ventricular-internal-dimension-at 
end-systole, spontaneous echocontrast, pericardial effusion and 
increased cTnI). Although the spontaneous echocontrast, peri-
cardial effusion and increased cTnI often completely resolved 
in the study dogs following immunosuppressive therapy, the 
decreased FS and increased normalised left-ventricular-internal-
dimension-at end-systole did not always return to normal values 
and in some cases deteriorated further. The mean age and breeds 
of the animals in this study were relatively typical of those affected 
with SRMA, and boxers and beagles were overrepresented as in 
previous studies (Harcourt 1978, Poncelet & Balligand 1993, 
Lowrie et al. 2009b).
The most common abnormality (12 of 14 cases) identified on 
echocardiography was of spontaneous echocontrast, which is a 
characteristic swirling echogenicity of blood in the heart cham-
bers or blood vessels on echocardiography (Bayar et al. 2016). It 
is thought to be due to changes in blood flow or haematological 
abnormalities. Reported risk factors for spontaneous echocon-
trast in dogs and humans include increased fibrinogen levels, 
red cell distribution width, haematocrit, haemoglobin content, 
hypercoagulability and platelet size and decreased shear rate 
(Sigel et al. 1983, Ralph et al. 2011, Bayar et al. 2016). Under 
normal circumstances, red blood cells are repelled from each 
other because of their similar electrical charge but macromol-
ecules such as fibrinogen alter and reduce these repulsive forces 
(Fatkin et al. 1997).
It has been shown that mean platelet volume is higher in 
humans with rheumatic mitral stenosis with spontaneous echo-
contrast, than those without (Bayar et al. 2016). Larger platelets 
are thought to be more active, increasing the potential for red 
blood cell aggregation, although its clinical relevance is unknown 
(Balcý et al. 2016). In veterinary medicine, it has been shown 
that dogs with septic peritonitis have larger platelets compared to 
healthy dogs (Llewellyn et al. 2017). On review of the results from 
this study, 11 of 14 patients had mean platelet volume measured 
before receiving prednisolone and it was above the normal refer-
ence range in three of 11 of these patients (median 11 fL, range 
9.2 to 15.8; reference 7.78 to 13.14). No breeds genetically pre-
disposed to having large platelets, such as the cavalier King Charles 
spaniel, were included in this study and therefore these results may 
be of significance and warrant further investigation in the future.
Spontaneous echo contrast has been reported previously in 
three dogs, secondary to systemic inflammatory conditions 
(including endocarditis, Evan’s syndrome and sepsis) resulting 
in hyperfibrinogenaemia and platelet activation (Ralph et al. 
2011). Echocardiography was repeated in only one patient, with 
resolution of the spontaneous echocontrast at 2 weeks but no 
patients showed signs of cardiac disease. All patients were started 
on thromboprophylactic therapy but none developed signs of 
thromboembolic disease.
In our case series we documented that fibrinogen was increased 
in 11 of 12 cases with SRMA. Fibrinogen is a positive acute phase 
protein similar to globulin and CRP so it is not surprising that 
it is increased in dogs with a focal or systemic inflammatory dis-
ease such as SRMA. Hyperfibrinogenaemia was not consistently 
associated with spontaneous echocontrast (cases 4 and 6 had 
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increased fibrinogen but no spontaneous echocontrast and case 
10 had normal fibrinogen but did have spontaneous echocon-
trast). In addition, the magnitude of the increase in CRP did 
not seem to be associated with spontaneous echocontrast. This 
indicates that other factors apart from hyperfibrinogenaemia and 
increased CRP must be involved in the spontaneous echocontrast 
that occurs in some dogs with SRMA. This could include changes 
in blood flow, haemotaocrit, haemoglobin concentration, mean 
platelet volume or platelet activity and should be further assessed 
using routine haematology, blood pressure measurement, heart 
rate recording and platelet function analysis in the future.
In humans, spontaneous echocontrast has been associated 
with an increased incidence of thromboembolic disease (Rader 
et al. 2007). Although most studies suggest that platelets do not 
directly cause spontaneous echocontrast but, instead, are acti-
vated due to increased red blood cell aggregation or pro-inflam-
matory states (Fatkin et al. 1997), antiplatelet therapy may still 
be beneficial in the initial management of patients with SRMA. 
This could be of clinical importance, given that complications 
due to vascular thrombosis have been reported in SRMA (Spitz-
barth et al. 2012). Conversely, haemorrhage has been reported 
in dogs with SRMA and therefore both pro- and antithrombotic 
states must be considered and investigated further (Hughes et al. 
2015, Brocal et al. 2017).
In this small case series, no antiplatelet or antithrombotic treat-
ments were prescribed and no obvious thrombotic complications 
occurred. Previous work (de la Fuente et al. 2012) documented 
that dogs with SRMA have increased fibrinolytic activity in their 
CSF as documented by increased CSF D-dimer concentration. 
D-dimers are specific markers of fibrinolysis and it would be use-
ful to further examine markers of thrombosis (using D-dimers 
and fibrinogen degradation products) in dogs with SRMA. 
Assessment of coagulation using thromboelastography or a plate-
let function analyser could also assist in determining other factors 
involved in spontaneous echocontrast in cases of canine SRMA. 
This could help determine whether antithrombotic or antiplatelet 
therapy is warranted and whether it is effective.
Cardiac troponin I was measured as an adjunctive method 
of assessing for cardiac myocyte injury, which could occur as a 
consequence of myocarditis or secondary to an ischaemic injury. 
Cardiac troponin I was increased in all patients at baseline 
and normalised with treatment in all but one. Although cTnI 
remained increased in that patient, spontaneous echocontrast had 
resolved. This dog had concurrent mild subaortic stenosis with 
mild aortic regurgitation. The increased troponin of 2.47 ng/L 
is consistent with acute myocardial injury and therefore primary 
cardiac disease other than subaortic stenosis (such as a thrombo-
embolic episode with ischaemic injury) must be considered in 
this case. In a previous report of a patient with increased cTnI 
and spontaneous echocontrast (Navarro-Cubas et al. 2011), 
the troponin normalised within 2  weeks of treatment, despite 
being markedly increased at 16.6 ng/L. Therefore, further work 
is required to determine the extent and timing of cTnI increase 
that occurs with inflammatory conditions.
A recent case series (Covey & Connolly 2018) documented 
cardiac changes in seven dogs with systemic inflammatory dis-
eases, including five with SRMA. All dogs had mild pericardial 
effusion (not requiring pericardiocentesis) and all had increased 
cTnI, but none had spontaneous echocontrast. Interestingly, five 
of seven of these patients had evidence of left venricular systolic 
dysfunction (decreased FS) on initial echocardiography, includ-
ing four of five with SRMA. Repeat echocardiography was per-
formed between 4 and 6 days in four patients and at 24 days in 
one patient. Although pericardial effusion resolved in all dogs, 
left ventricular systolic dysfunction persisted in three of four dogs 
with repeat echocardiography. These findings are similar to our 
present case series, in which five of 14 patients had reduced FS 
at presentation; only two dogs showed improvement with treat-
ment, while three had persistent left ventricular systolic dysfunc-
tion and two additional patients developed reduced FS on repeat 
echocardiography. Neither the present study nor Covey & Con-
nolly (2018) assessed positive inotropic therapy in these patients. 
Further investigation into systolic function in patients with sys-
temic inflammation is required to determine whether systolic 
dysfunction is a negative prognostic indicator and whether posi-
tive inotropic therapy is indicated in the short and long term. 
The finding of persistent or new systolic dysfunction noted in 
some cases following treatment for SRMA is interesting and war-
rants further investigation.
In the Covey & Connolly (2018) study, two other patients with 
inflammatory disease and pericardial effusion were described: 
one with pleural effusion and one with systemic inflammatory 
response syndrome (SIRS) of unknown aetiology. SRMA his-
tologically causes fibrinoid arteritis which has been reported to 
affect the coronary vessels as well as meningeal vessels, result-
ing in altered vascular permeability that could potentially cause 
pericardial effusion (Tipold & Schatzberg 2010). However, the 
pericardial effusion noted in the two cases discussed by Covey & 
Connolly (2018) which did not have SRMA suggests a secondary 
mechanism for the development of pericardial effusion, the most 
likely of which being inflammatory cytokine induced dysfunc-
tion in vascular permeability (Snyder et al. 1995).
Multiple aetiologies have also been proposed to explain left 
ventricular systolic dysfunction in patients with systemic inflam-
matory diseases. Inflammatory cytokines such as tumour necro-
sis factor alpha (TNF-α), interleukin-6 (IL-6) and interleukin-1 
(IL-1) have been associated with SIRS-induced myocardial 
dysfunction in both humans (Ungureanu-Longrois et al. 1995, 
Stein et al. 1996) and dogs (Butler et al. 2008). Other mecha-
nisms leading to poor contractility include hypotension, hypoxia 
and lactic acidosis (Nelson & Thompson 2006). This reduction 
in myocardial function is generally reversible in humans, with 
echocardiographic changes resolving within 7 to 10  days after 
the episode of septic shock (Bulmer 2011). This was not always 
seen in this case series or in those reported by Covey & Connolly 
(2018). Although all patients in this study recovered clinically 
with anti-inflammatory or immunosuppressive therapy, develop-
ment of myocardial dysfunction has been shown to be a negative 
prognostic indicator in patients with sepsis and SIRS (Nelson 
& Thompson 2006). Therefore, positive inotropic drugs such 
as pimobendan may be indicated in patients with inflammatory 
conditions and poor systolic function.
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Only two of five dogs with pericardial effusion had increased 
cTnI and it is suspected from this small case series that the effu-
sion and myocyte damage are different cardiac manifestations of 
systemic inflammation. There was no relationship between the 
CRP or fibrinogen levels and pericardial effusion, suggesting that 
effusion has a multifactorial origin and further investigation is 
required. Although all patients had an increase in CRP and the 
majority had increased fibrinogen when measured, the cTnI was 
not consistently increased. As CRP and fibrinogen are markers 
of inflammation and cTnI is a marker of myocyte damage, they 
provide different information. Further work is required to inves-
tigate why some dogs with systemic inflammation are subject to 
myocyte damage and pericardial effusion and others are not.
Limitations of this study include the small sample size and the 
lack of a control group of dogs containing spontaneous echo-
contrast, pericardial effusion or increased cTnI, but without the 
diagnosis of SRMA. Examination of systolic function was not a 
specific aim of this study and therefore more extensive echocar-
diography was not performed, and assessment of left ventricular 
systolic function was limited to FS and normalised left-ventric-
ular-internal-dimension-at end-systole. In addition, fibrinogen 
was not measured in all patients before treatment and was only 
measured in a small number of dogs after treatment. The three 
dogs without complete resolution of spontaneous echocontrast 
and the one dog which showed an increase in cTnI after treat-
ment did not have any further follow-up echocardiography or 
cTnI measurement, respectively. This lack of long-term follow-
up echocardiography is another limitation of our study. Cardiac 
assessment was incomplete as blood pressure was not measured or 
heart rate recorded in any of the dogs. Although echocardiogra-
phy was performed before sedation, anaesthesia or corticosteroid 
therapy at our hospital, one patient was sedated with medetomi-
dine before referral. Spontaneous echocontrast has been reported 
to be associated with bradycardia in dogs, in particular those that 
receive medetomidine (Kellihan et al. 2015). This patient had 
spontaneous echocontrast and increased fibrinogen but did not 
have an increase in cTnI or reduced FS. In this patient, alpha-2 
agonist administration could have contributed to the observed 
spontaneous echocontrast. Future studies are needed to more 
thoroughly assess systolic function in dogs with inflammatory 
conditions.
In conclusion, this study shows that cardiac abnormalities are 
common in patients with SRMA. Resolution of some of these 
changes (including spontaneous echocontrast and pericardial 
effusion) follow immunosuppressive therapy but left ventricular 
systolic dysfunction can persist in some cases. These findings are 
similar to those found in humans with inflammatory conditions 
including CNS disease. The presence of cardiac abnormalities 
could not be predicted based on the CRP or fibrinogen levels. 
Further studies are required to determine the cause of these 
changes and to assess whether or not anti-thrombotic medica-
tions or positive inotropic therapy should be considered in the 
management of canine patients with SRMA.
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